Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery

Author(s):
PosthumaDeBoer, J.; Piersma, S.R.; Pham, T.V.; Egmond, P.W. van; Knol, J.C.; Cleton-Jansen, A.M.; Geer, M.A. van; Beusechem, V.W. van; Kaspers, G.J.L.; Royen, B.J. van; Jimenez, C.R.; Helder, M.N.
Published
2013
Publication type
Article / Letter to editor
osteosarcomaproteomicstargeted therapydrug deliveryEPHA2
Date issued
2013-10-15
Language
English
Is part of
British Journal of Cancer (2013), Vol. 109, no. 8, p. 2142-2154
hdl
1887/104910
doi
10.1038/bjc.2013.578